Life After s Loss: Impact of Hepatitis B s Antigen Loss on Future Patient Outcomes
Daniel Q. Huang, Seng Gee Lim – 12 January 2021
CON: Liver Transplant Alone
Gina Choi – 12 January 2021
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable
Radha K. Dhiman, Madhumita Premkumar – 12 January 2021
Alcohol‐Associated Liver Disease: East Versus West
Phunchai Charatcharoenwitthaya, Suthat Liangpunsakul, Teerha Piratvisuth – 12 January 2021
PBC: No Longer a Western Disease?
Atsushi Tanaka – 12 January 2021
Optimal Modalities for HCC Surveillance in a High‐Incidence Region
Young Chang, Jeong‐Hoon Lee – 12 January 2021
PRO: Simultaneous Liver‐Kidney Transplantation in the Current Era: Still the Best Option
C. Kristian Enestvedt – 12 January 2021
Introduction: Liver Disease in Asia
Kazuhiko Koike, W. Ray Kim – 12 January 2021
Dual Agonist of Farnesoid X Receptor and Takeda G Protein‐Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo
Kiyoaki Ito, Akinori Okumura, Junko S. Takeuchi, Koichi Watashi, Rieko Inoue, Taeko Yamauchi, Kazumasa Sakamoto, Yukiko Yamashita, Yusuke Iguchi, Mizuho Une, Takaji Wakita, Kazuo Umezawa, Masashi Yoneda – 11 January 2021
Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma
Sharanya Maanasi Kalasekar, Ignacio Garrido‐Laguna, Kimberley Jane Evason – 11 January 2021